Simone Seiter

Director/Board Member at GENSIGHT BIOLOGICS S.A.

59 year

Health Technology

Consumer Services

Finance

Profile

Simone Seiter is the founder of Priothera SAS. Current job includes Independent Director at Gensight Biologics SA since 2017.
Former jobs include Deputy Chairman-Supervisory Board at AGROB Immobilien AG, Vice President at IQVIA from 2006 to 2019, and Senior Partner at Simon-Kucher & Partners, Inc. Education includes a doctorate from Ruprecht-Karls-Universität Heidelberg and an MBA from Neu-Ulm University of Applied Sciences.

Simone Seiter active positions

Companies	Position	Start
GENSIGHT BIOLOGICS S.A.	Director/Board Member	19/04/2017
Priothera SAS Priothera SAS BiotechnologyHealth Technology Provides drug and clinical development services	Founder	-

All active positions of Simone Seiter

Former positions of Simone Seiter

Companies	Position	End
IQVIA	Corporate Officer/Principal	01/01/2019
AGROB IMMOBILIEN AG	Director/Board Member	-
Simon-Kucher & Partners, Inc.	Corporate Officer/Principal	-

See the detail of Simone Seiter's experience

Training of Simone Seiter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Simone Seiter's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
AGROB Immobilien AG AGROB Immobilien AG Real Estate DevelopmentFinance Operates as a real estate company with interest in rental and leasing of commercial, industrial and residential real estate properties	Finance
Ruprecht-Karls-Universität Heidelberg Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Neu-Ulm University of Applied Sciences Neu-Ulm University of Applied Sciences Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gensight Biologics SA Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases	Health Technology
IQVIA
Simon-Kucher & Partners, Inc.
Priothera SAS Priothera SAS BiotechnologyHealth Technology Provides drug and clinical development services	Health Technology